Postdoctoral Research Fellow in Translational Nanomedicine and mRNA Therapeutics for Cancer Immunotherapy

The Nanomedicine and Gene Therapeutics Laboratory (NGTL) at the Olivia Newton-John Cancer Research Institute, affiliated with La Trobe University, is seeking a Postdoctoral Research Fellow to join their team in Melbourne, Australia. This position focuses on translational nanomedicine, specifically the development and evaluation of targeted mRNA delivery systems using lipid nanoparticles (mRNA–LNPs) for next-generation cancer immunotherapy. The successful candidate will work on clinically relevant models, leveraging strong clinical collaborations and access to patient-derived samples and established workflows. Key research areas include nanomedicine, mRNA therapeutics, cancer immunotherapy, lipid nanoparticle technology, and translational research. The role is ideal for candidates passionate about advancing cancer treatment through innovative drug delivery systems and gene therapeutics. The laboratory offers a collaborative environment with opportunities to engage in cutting-edge research and contribute to impactful clinical outcomes. Applicants should hold a PhD in biomedical engineering, medical science, biology, or a related discipline. Experience in nanomedicine, mRNA therapeutics, cancer research, or lipid nanoparticle systems is highly desirable. The position is a paid postdoctoral fellowship, though specific funding details are not provided. Interested candidates are encouraged to apply via Seek and can learn more about the NGTL through the provided links. This opportunity is suitable for researchers aiming to advance their careers in translational cancer research and nanomedicine.